Skip to main content

Comorbid conditions in subjects with rheumatic diseases

Rheumatic diseases have a significant burden and impact on healthcare systems and are one of the most common causes of disability and work-related absences. However, in addition to the disease burden itself, patients with rheumatic diseases are also at an increased risk of developing a variety of comorbid conditions. These comorbid conditions can arise as a result of the disease itself, but also from its treatment. Over recent years, a growing list of comorbidities have been identified that are frequently associated with rheumatic diseases and these include: malignancies, cardiovascular diseases, infections, kidney diseases, lung diseases, sexual dysfunction, dental, and skin issues to name just a few. These comorbidities have a significant effect on the lives of patients and therefore it is important to increase our understanding of these conditions to ensure optimal treatment and improvements in quality of life.

Read the published content in this thematic series covering aspects of research into rheumatic diseases co-morbidities ranging from sexual to cardiovascular function. BMC Rheumatology would like to thank all authors and Editorial Board members who contributed to this collection. Future Thematic Series can be proposed by contacting the Editorial Office of the journal:

  1. The liver is often overlooked as a target organ, with pathology either secondary to an underlying disease or due to the toxicity of therapies and the medical complications of extrahepatic diseases. It is thus ...

    Authors: Carlo Selmi, Maria De Santis and M Eric Gershwin
    Citation: Arthritis Research & Therapy 2011 13:226
  2. Management of patients with inflammatory rheumatic disease and a history of (or even a current) malignant disease poses some particular challenges. As direct evidence of the risk of (recurrent or de novo) maligna...

    Authors: Katarzyna Elandt and Daniel Aletaha
    Citation: Arthritis Research & Therapy 2011 13:223
  3. Renal co-morbidity is common in patients with rheumatic disease based on regular assessment of serum and urine parameters of renal function. When patients present with both arthritis and renal abnormalities th...

    Authors: Hans-Joachim Anders and Volker Vielhauer
    Citation: Arthritis Research & Therapy 2011 13:222